Rivastigmine hydrogen tartrate
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151549This classification denotes an acetylcholinesterase inhibitor with the molecular formula C14H22N2O2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9IY2357JPE, chemically known as 2,6-dioxo-4-phenyl-piperidine-3-carbonitrile but more generally known as rivastigmine hydrogen tartrate, which bears US NIH Compound Identifier 77991. European Medicines Agency schedules Rivastigmine hydrogen tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04257MIG. Most nations, for tariff and trade purposes, schedule rivastigmine hydrogen tartrate under HS 29242995 and SITC 51479. SMILES: CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.